Cardioprotective effects of ozone oxidative preconditioning in an in vivo model of ischemia/reperfusion injury in rats

Scandinavian Journal of Clinical and Laboratory Investigation

Volumn 72, Issue 5, 2012, Pages 345-354

  Ahmed, Lamiaa A ^a   Salem, Hesham A ^a   Mawsouf, Mohamed N ^b   Attia, Amina S ^a   Agha, Azza M ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Arrhythmias; Ischemia; Ozone; Preconditioning; Reperfusion

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; CREATINE KINASE MB; GLUTATHIONE; LACTIC ACID; MYELOPEROXIDASE; NITRATE; NITRITE; OZONE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

AERATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG EFFECT; ENZYME ACTIVITY; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART RATE; HEART VENTRICLE ARRHYTHMIA; HISTOPATHOLOGY; IN VIVO STUDY; ISCHEMIC PRECONDITIONING; LACTATE BLOOD LEVEL; MALE; NONHUMAN; OZONE THERAPY; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

ADENINE NUCLEOTIDES; ANIMALS; CARDIOTONIC AGENTS; CREATINE KINASE, MB FORM; GLUTATHIONE; HEART; HEART RATE; HEART VENTRICLES; LACTIC ACID; MALE; MYOCARDIAL REPERFUSION INJURY; OXIDATIVE STRESS; OZONE; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84865344737     PISSN: 00365513     EISSN: 15027686     Source Type: Journal    
DOI: 10.3109/00365513.2012.663100     Document Type: Article

References (58)

1. Laskey WK. Brief repetitive ballon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: a pilot study. Catheter Cardiovasc Interv 2005;65:361-7. (Pubitemid 40898179)
2. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-36. (Pubitemid 17174962)
3. Schott RJ, Rohmann S, Braun ER, Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 1990;66:1133-42. (Pubitemid 20126444)
4. Toosy N, McMorris EL, Grace PA, Mathie RT. Ischemic preconditioning protects the rat kidney from reperfusion injury. BJU Int 1999;84:489-94. (Pubitemid 29419421)
5. Yellon DM, Hausenloy DJ. Mechanisms of disease. Myocardial reperfusion injury. N Eng J Med 2007;357:1121-35.
6. Park KM, Chen A, Bonventre JV. Prevention of kidney ischemia/ reperfusion-induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. J Biol Chem 2001;276:11870-6.
7. Vaage J, Valen G. Preconditioning and cardiac surgery. Ann Thorac Surg 2003;75:709-14.
8. Borrego A, Zamora ZB, González R, Romay C, Menéndez S, Hern ández F, Montero T, Rojas E. Protection by ozone preconditioning is mediated by the antioxidant system in cisplatin-induced nephrotoxicity in rats. Mediators Inflamm 2004;13:13-9. (Pubitemid 38621644)
9. Romero A, Menéndez S, Gómez M, Ley J. Ozone therapy in the advanced stages of arteriosclerosis obliterans. Angiologia 1993;45:146-8.
10. Hernandez F, Menendez S, Wong R. Decrease of blood cholesterol and stimulation of antioxidative response on cardiopathy patients treated with endovenous ozone therapy. Free Rad Biol Med 1995;19:115-9.
11. Barber E, Menéndez S, León OS, Barber MO, Merino N, Calunga JL, Cruz E, Bocci V. Prevention of renal injury after induction of ozone tolerance in rats submitted to warm ischemia. Mediators Inflamm 1999;8:37-41. (Pubitemid 29195655)
12. Chen H, Xing B, Liu X, Zhan B, Zhou J, Zhu H, Chena Z. Similarities between ozone oxidative preconditioning and ischemic preconditioning in renal ischemia/reperfusion injury. Arch Med Res 2008;39:169-78. (Pubitemid 350299621)
13. Bocci V. Ozone as Janus: this controversial gas can be either toxic or medically useful. Mediators Inflamm 2004;13:3-11. (Pubitemid 38621643)
14. Re L, Mawsouf MN, Men éndez S, Le ón OS, S án chez GM, Hern ández F. Ozone therapy: clinical and basic evidence of its therapeutic potential. Arch Med Res 2008;39:19-26.
15. Le ón OS, Menéndez S, Merino N, Castillo R, Sam S, Pérez L, Cruz E, Bocci V. Ozone oxidative preconditioning: a protection against cellular damage by free radicals. Mediators Inflamm 1998;7:289-94. (Pubitemid 28419524)
16. Peralta C, León OS, Xaus C, Prats N, Candelario-Jalil E, Sala-Planell E, Puig-Parellada P, Gelp íE, Rosell ó-Catafau J. Protective effect of ozone treatment on the injury associated with hepatic ischemia-reperfusion: antioxidantprooxidant balance. Free Rad Res 1999;31:191-6. (Pubitemid 29435880)
17. Candelario-Jalil E, Mohammed-Al-Dalain S, Fernandez OS. Oxidative preconditioning affords protection against carbon tetrachloride-induced glycogen depletion and oxidative stress in rats. J Appl Toxicol 2001;21:297-301. (Pubitemid 32755701)
18. Bocci V. Does ozone therapy normalize the cellular redox balance? Implications for therapy of human immunodefi - ciency virus infection and several other diseases. Med Hypotheses 1996;46:150-4. (Pubitemid 26075778)
19. Peralta C, Xaus C, Bartrons R, León OS, Gelp íE, Rosell ó-Catafau J. Effect of ozone treatment on reactive oxygen species and adenosine production during hepatic ischemia-reperfusion. Free Rad Res 2000;33:595-605. (Pubitemid 32103700)
20. Ajamieh H, Merino N, Candelario-Jalil E, Menéndez S, Martinez-sanchez G, Re L, Giuliani A, Leon OS. Similar protective effect of ischaemic and ozone oxidative preconditionings in liver ischaemia/reperfusion injury. Pharmacol Res 2002;45:333-9. (Pubitemid 35430529)
21. Sahna E, Parlakpinar H, Turkoz Y, Acet A. Protective effects of melatonin on myocardial ischemia-reperfusion induced infarct size and oxidative changes. Physiol Res 2005;54:491-5. (Pubitemid 41578671)
22. W alker MJA, Curtis MJ, Hearse DJ, Campbell RWF, Janse MJ. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res 1988;22:447-55.
23. Curtis MJ, Walker MJA. Quantifi cation of arrhythmias using scoring systems: an examination of seven scores in an in vivo model of regional ischaemia. Cardiovasc Res 1988;22: 656-65.
24. Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric oxide Biol Chem 2001;5:62-71. (Pubitemid 34146173)
25. Noll F. L-(+)-Lactate. In: Bergmeyer HU, editor. Methods of enzymatic analysis, 3rd ed. Weinheim, Germany: VCHVerlagsgesellschaft, 1985. pp. 582-8.
26. Teerlink T, Hennekes M, Bussemaker J, Groeneveld J. Simultaneous determination of creatine compounds and adenine nucleotides in myocardial tissue by high-performance liquid chromatography. Anal Biochem 1993;214:278-83. (Pubitemid 23300385)
27. Hermes-Lima M, Willmore WG, Storey KB. Quantifi cation of lipid peroxidation in tissue extracts based on Fe(III)xylenol orange complex formation. Free Rad Biol Med 1995; 19:271-80.
28. Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963;61:882-8.
29. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206-09. (Pubitemid 12171880)
30. Yellon DM, Downey JM. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 2003;83:1113-51. (Pubitemid 37222269)
31. Reddy HK, Koshy SKG, Shukia H. Triggers and promoters of ischaemic preconditioning. Cardiovasc Res 2002;56:1-3. (Pubitemid 35247795)
32. Hearse DJ, Tosaki A. Free radicals and calcium: simultaneous interacting triggers as determinants of vulnerability to reperfusion-induced arrhythmias in the rat heart. Mol Cell Cardiol 1988;20:213-23.
33. Cascio WE, Johnson TA, Gettes LS. Electrophysiologic changes in ischemic ventricular myocardium: infl uence of ionic, metabolic and energetic changes. Cardiovasc Electrophysiol 1995;11:1039-62.
34. Zipes DP. Mechanisms of clinical arrhythmias. Cardiovasc Electrophysiol 2003;14:902-12. (Pubitemid 36994115)
35. Dhalla NS, Elmoselhi AB, Hata T, Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovas Res 2000;47:446-56. (Pubitemid 30646067)
36. Qu F, Qin XQ, Cui YR, Xiang Y, Tan YR, Liu HJ, Peng LH, Zhou XY, Liu C, Zhu XL. Ozone stress down-regulates the expression of cystic fi brosis transmembrane conductance regulator in human bronchial epithelial cells. Chem Biol Interact 2009;179:219-26.
37. Peuhkurinen KJ. Ischemic heart disease at the cellular level. IJBEM 2000;2:1-8 .
38. Gustafsson AB, Gottlieb RA. Heart mitochondria: gates of life and death. Cardiovasc Res 2008;77:334-43. (Pubitemid 351197632)
39. Mani K. Programmed cell death in cardiac myocytes: strategies to maximize post-ischemic salvage. Heart Failure Rev 2008;13:193-209.
40. Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to ischaemia/reperfusion injury on rat liver in vivo. FASEB J 1990;4:3355-9. (Pubitemid 120012584)
41. Guven A, Uysal B, Akgul O. Scavenging of peroxynitrite reduces renal ischemia/reperfusion injury. Ren Fail 2008; 30:747-54.
42. Tunc T, Uysal B, Atabek C, Kesik V, Caliskan B, Oztas E, Ersoz N, Oter S, Guven A. Erdosteine and ebselen as useful agents in intestinal ischemia/reperfusion injury. J Surg Res 2008;155:210-6.
43. Zweier JL, Talukder MAH. The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res 2006;70:181-90.
44. Godber BLJ, Doel JJ, Sapkota GP. Reduction of nitrite to nitric oxide catalyzed by xanthine oxidoreductase. Biol Chem 2000;275:7757-63. (Pubitemid 30159680)
45. Kitakaze M, Node K, Takashima S. Role of cellular acidosis in production of nitric oxide in canine ischemic myocardium. J Mol Cell Cardiol 2001;33:1727-37. (Pubitemid 32844230)
46. Beckman JS, Koppenol WH. Nitric oxide, superoxide and peroxynitrite: the good, the bad, and ugly. Am J Physiol Cell Physiol 1996;271:C1424-37.
47. Clementi E, Brown GC, Feelisch M, Moncada S. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci 1998;95:7631-6. (Pubitemid 28293304)
48. Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281:1312-5.
49. Guven A, Gundogdua G, Vurucub S, Uysalc B, Oztasd E, Ozturka H, Korkmazc A. Medical ozone therapy reduces oxidative stress and intestinal damage in an experimental model of necrotizing enterocolitis in neonatal rats. J Pediatr Surg 2009;44:1730-5.
50. Canning BJ, Hmieleski RR, Spannhake EW, Jakab GJ. Ozone reduces murine alveolar and peritoneal macrophage phagocytosis: the role of prostanoids. Am J Physiol 1991;261:277-82.
51. Novelli GP. Role of free radicals in septic shock. J Physiol Pharmacol 1997;48:517-27. (Pubitemid 28055584)
52. Al-Dalaina SM, Martíneza G, Candelario-Jalila E, Menéndezb S, Rec L, Giulianid A, Le óna OS. Ozone treatment reduces markers of oxidative and endothelial damage in an experimental diabetes model in rats. Pharmacol Res 2001;44:391-6.
53. Zweier JL, Flaherty JT, Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci 1987;84:1404-7. (Pubitemid 17027362)
54. Ambrosio G, Flaherty JT, Duilio C. Oxygen radicals generated at refl ow induce peroxidation of membrane lipids in reperfused hearts. J Clin Invest 1991;87:2056-66.
55. Verbunt R, Van der Laarse A. Glutathione metabolism in non-ischemic and postischemic rat hearts in response to an exogenous prooxidant. Mol Cell Biochem 1997;167: 127-34. (Pubitemid 27081340)
56. Solaini G, Harris DA. Biochemical dysfunction in heart mitochondria exposed to ischemia and reperfusion. Biochem J 2005;390:377-94. (Pubitemid 41337100)
57. Jennings RB, Reimer KA, Steenbergen C. Effect of inhibition of the mitochondrial ATPase on net myocardial ATP in total ischemia. J Mol Cell Cardiol 1991;23:1383-95.
58. Ylitalo K, Ala Rami A, Vuorinen K, Peuhkurinen K, Lepojarvi M, Kaukoranta P, Kiviluoma K, Hassinen I. Reversible ischaemic inhibition of F1F0-ATPase in rat and human myocardium. Biochim Biophys Acta 2001;1504:329-39. (Pubitemid 32201904)